Literature DB >> 27330786

Case series of cerebral infarction with Trousseau's syndrome associated with malignant gynecological tumors.

Masako Ishikawa1, Kentaro Nakayama1, Tomoka Ishibashi1, Emi Sato1, Kohei Nakamura1, Hiroshi Katagiri1, Satoru Kyo1.   

Abstract

The association between neoplastic disease and thromboembolic disorders was first recognized by Trousseau in 1865. Blood coagulation abnormalities have been reported in the majority of patients with cancer, including those with ovarian carcinoma. However, Trousseau's syndrome (TS) has rarely been reported in women with ovarian carcinoma. We herein report a case series of TS, notably in the brain, in association with gynecological malignant disease, and emphasize the difficulties associated with the management of these thromboembolic effects. The aim of this study was to present our experience with 5 TS patients whose condition was effectively controlled through treatment of the primary malignant disease. Therefore, we suggest that patients with TS may be cured by tumor resection, even if they have severe thromboembolic disease, such as cerebral or pulmonary infarction.

Entities:  

Keywords:  Trousseau's syndrome; cerebral infarction; endometrial cancer; ovarian cancer; surgery; thromboembolism; unfractionated heparin

Year:  2016        PMID: 27330786      PMCID: PMC4906824          DOI: 10.3892/mco.2016.888

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  17 in total

1.  Trousseau's syndrome: thrombophlebitis with carcinoma.

Authors:  S VERNON
Journal:  J Abdom Surg       Date:  1961-09

2.  Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome.

Authors:  Bojing Shao; Mark G Wahrenbrock; Longbiao Yao; Tovo David; Shaun R Coughlin; Lijun Xia; Ajit Varki; Rodger P McEver
Journal:  Blood       Date:  2011-08-22       Impact factor: 22.113

3.  Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

Authors:  N Levitan; A Dowlati; S C Remick; H I Tahsildar; L D Sivinski; R Beyth; A A Rimm
Journal:  Medicine (Baltimore)       Date:  1999-09       Impact factor: 1.889

Review 4.  The heparins and cancer: review of clinical trials and biological properties.

Authors:  Roberto Castelli; Fernando Porro; Paolo Tarsia
Journal:  Vasc Med       Date:  2004-05       Impact factor: 3.239

Review 5.  Therapeutic equivalency of low-molecular-weight heparins.

Authors:  Gary M McCart; Steven R Kayser
Journal:  Ann Pharmacother       Date:  2002-06       Impact factor: 3.154

6.  Low-molecular-weight heparin in the management of Trousseau's syndrome.

Authors:  D Walsh-McMonagle; D Green
Journal:  Cancer       Date:  1997-08-15       Impact factor: 6.860

7.  Trousseau's syndrome. Devastating coagulopathy in the absence of heparin.

Authors:  W R Bell; N F Starksen; S Tong; J K Porterfield
Journal:  Am J Med       Date:  1985-10       Impact factor: 4.965

8.  Safety and efficacy of long-term oral anticoagulation in cancer patients.

Authors:  D Krauth; A Holden; N Knapic; M Liepman; J Ansell
Journal:  Cancer       Date:  1987-03-01       Impact factor: 6.860

Review 9.  Stroke in patients with cancer: incidence and etiology.

Authors:  D M Cestari; D M Weine; K S Panageas; A Z Segal; L M DeAngelis
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

10.  Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.

Authors:  Guy Meyer; Zora Marjanovic; Judith Valcke; Bernard Lorcerie; Yves Gruel; Philippe Solal-Celigny; Christine Le Maignan; Jean Marc Extra; Paul Cottu; Dominique Farge
Journal:  Arch Intern Med       Date:  2002 Aug 12-26
View more
  6 in total

1.  Four cases of Trousseau syndrome associated with breast cancer that exhibited central nervous system manifestations.

Authors:  Mai Okazaki; Hiroko Bando; Emika Ichioka; Akiko Iguchi-Manaka; Katsuhiro Nasu; Hisato Hara
Journal:  Int Cancer Conf J       Date:  2020-04-04

2.  Clinical associations of Trousseau's syndrome associated with cerebral infarction and ovarian cancer.

Authors:  Hirokuni Takano; Keiko Nakajima; Yoko Nagayoshi; Hiromi Komazaki; Jiro Suzuki; Hiroshi Tanabe; Shigeki Niimi; Seiji Isonishi; Aikou Okamoto
Journal:  J Gynecol Oncol       Date:  2018-04-23       Impact factor: 4.401

3.  Clinical Manifestations and Mechanisms of Autoimmune Disease-Related Multiple Cerebral Infarcts.

Authors:  Li-Li Sun; Wen-Xiong Tang; Min Tian; Lu Zhang; Zun-Jing Liu
Journal:  Cell Transplant       Date:  2019-05-07       Impact factor: 4.064

4.  Importance of Standard Treatment in Prognosis of Patients with Ovarian Cancer and Associated Cerebral Infarction.

Authors:  Zhen Yuan; Dongyan Cao; Mei Yu; Huimei Zhou; Ying Zhang; Jiaxin Yang; Keng Shen
Journal:  Clin Interv Aging       Date:  2020-02-05       Impact factor: 4.458

5.  Adenomyosis-associated recurrent acute cerebral infarction mimicking Trousseau's syndrome: A case study and review of literature.

Authors:  Nobuhiko Arai; Kazunari Yachi; Ryutaro Ishihara; Takao Fukushima
Journal:  Surg Neurol Int       Date:  2022-04-29

6.  Trousseau's Syndrome Presenting as Multiple Cerebral Infarctions Caused by Mucin-producing Bladder Micropapillary Urothelial Cancer.

Authors:  Sho Shimohama; Koichi Oki; Hidefumi Narita; Kyoko Mashima; Satoshi Yamada; Tomohide Adachi; Yosuke Kobayashi; Shigemichi Hirose; Haruhiko Hoshino
Journal:  Intern Med       Date:  2021-06-26       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.